Suppr超能文献

椎管内可乐定与慢性丁丙诺啡治疗产妇剖宫产术后阿片类药物消耗或疼痛评分降低无关:一项回顾性队列研究。

Neuraxial clonidine is not associated with lower post-cesarean opioid consumption or pain scores in parturients on chronic buprenorphine therapy: a retrospective cohort study.

机构信息

Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, USA.

Department of Anesthesiology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA.

出版信息

J Anesth. 2024 Jun;38(3):339-346. doi: 10.1007/s00540-024-03314-8. Epub 2024 Mar 10.

Abstract

PURPOSE

Adequate post-cesarean delivery analgesia can be difficult to achieve for women diagnosed with opioid use disorder receiving buprenorphine. We sought to determine if neuraxial clonidine administration is associated with decreased opioid consumption and pain scores following cesarean delivery in women receiving chronic buprenorphine therapy.

METHODS

This was a retrospective cohort study at a tertiary care teaching hospital of women undergoing cesarean delivery with or without neuraxial clonidine administration while receiving chronic buprenorphine. The primary outcome was opioid consumption (in morphine milligram equivalents) 0-6 h following cesarean delivery. Secondary outcomes included opioid consumption 0-24 h post-cesarean, median postoperative pain scores 0-24 h, and rates of intraoperative anesthetic supplementation. Multivariable analysis evaluating the adjusted effects of neuraxial clonidine on outcomes was conducted using linear regression, proportional odds model, and logistic regression separately.

RESULTS

196 women met inclusion criteria, of which 145 (74%) received neuraxial clonidine while 51 (26%) did not. In univariate analysis, there was no significant difference in opioid consumption 0-6 h post-cesarean delivery between the clonidine (8 [IQR 0, 15]) and control (1 [IQR 0, 8]) groups (P = 0.14). After adjusting for potential confounders, there remained no significant association with neuraxial clonidine administration 0-6 h (Difference in means 2.77, 95% CI [- 0.89 to 6.44], P = 0.14) or 0-24 h (Difference in means 8.56, 95% CI [- 16.99 to 34.11], P = 0.51).

CONCLUSION

In parturients receiving chronic buprenorphine therapy at the time of cesarean delivery, neuraxial clonidine administration was not associated with decreased postoperative opioid consumption, median pain scores, or the need for intraoperative supplementation.

摘要

目的

对于接受丁丙诺啡治疗的诊断为阿片类药物使用障碍的女性,充分的剖宫产术后镇痛可能难以实现。我们旨在确定在接受慢性丁丙诺啡治疗的女性行剖宫产术时,椎管内给予可乐定是否与术后阿片类药物消耗减少和疼痛评分降低相关。

方法

这是一项在三级教学医院进行的回顾性队列研究,研究对象为接受慢性丁丙诺啡治疗的女性,在接受或不接受椎管内可乐定治疗的情况下行剖宫产术。主要结局是剖宫产术后 0-6 小时内的阿片类药物消耗(以吗啡毫克当量计)。次要结局包括剖宫产术后 0-24 小时的阿片类药物消耗、术后 0-24 小时的中位数疼痛评分以及术中麻醉补充的发生率。使用线性回归、比例优势模型和逻辑回归分别进行多变量分析,评估椎管内可乐定对结局的调整效果。

结果

196 名女性符合纳入标准,其中 145 名(74%)接受了椎管内可乐定治疗,51 名(26%)未接受。在单变量分析中,接受椎管内可乐定治疗的患者与对照组(8[IQR 0,15])相比,剖宫产术后 0-6 小时的阿片类药物消耗无显著差异(P=0.14)。调整潜在混杂因素后,椎管内可乐定给药与 0-6 小时(均数差异 2.77,95%CI[-0.89 至 6.44],P=0.14)或 0-24 小时(均数差异 8.56,95%CI[-16.99 至 34.11],P=0.51)的阿片类药物消耗均无显著相关性。

结论

在接受剖宫产术的同时接受慢性丁丙诺啡治疗的产妇中,椎管内可乐定给药与术后阿片类药物消耗减少、中位数疼痛评分降低或术中补充的需要无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验